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Objectives
The purpose of this project was to optimize the sensitivity of an existing analytical method to 
quantitate DMAA via derivatization using alkanoic anhydrides of varying molecular weight. 
Conclusions/Future Work
Introduction
The subject compound, 1,3-dimethylamylamine (DMAA), is a “natural” stimulant found in 
nutritional supplements, weight loss, and athletic performance-enhancing products. This 
amphetamine-like compound is linked to cardiovascular problems such as shortness of 
breath, arrhythmias, chest tightness, heart attacks, and multiple deaths [ref 1].  DMAA was 
banned in 2010 by the International Association of Athletics and the International Olympic 
Committee which both abide by the policies set forth by the World Anti-Doping Agency [ref 2].  
Our laboratory recently developed a quantitative method to determine the presence and 
amount of DMAA in commercial products by GC-FID and GC-MS.
Sample Preparation:  DMAA free base and Decane (C10) stock solutions were prepared in 
CHCl3 and derivatized with alkanoic anhydrides (acetic, propanoic, and butanoic) to give the 
corresponding amides. Trimethylamine (TEA) was added to aid in the derivatization (acylation). 
Experimental
* chiral center
DMAA-acetyl amide
*      *
DMAA-propanoyl amide DMAA-butanoyl amide
Results (cont’d)
Figure 1: Calibration Curve of GC-FID Response vs [DMAA-Ac] with 
out Internal Standard. 
Figure 3: Calibration curves for DMAA-amides by GC-FID and GC-MS
Results
Analytical Conditions:
• Agilent 7890A GC-FID:  Column Rtx – 5ms, 30 m x 0.25 mm x 0.25 mcm load, helium 
carrier gas flow = 1mL/minute, split flow = 50:1 
• Agilent 7890A/5975C GC-MSD:  ZB-5 30 m x 0.25 mm x 0.25 mcm load, helium carrier 
gas flow = 1mL/minute, split flow = 50:1
1,3-DMAA HCl salt
*      * *      *
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Figure 2: Calibration Curve of GC-FID Response vs 
[DMAA-Ac] with Internal Standard.
*          *
Product A
Product B
Figure 4: GC-MSD spectra of DMAA-amide derivatives (full scan)
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Quantitation of DMAA with and without Internal Standard
• In the quantitation of DMAA derivatized with acetic anhydride, calibration curves showed a 
marked improvement in fit and linearity with the addition of a Decane Internal Standard (Figs 1 
and 2).  
• Linear detector response was obtained for derivatives using both detection methods (FID and 
MSD, Fig 3).
• Sensitivity of the analytical method increased with increasing size of the derivatizing group (base 
< acetyl < propanoyl < butanoyl) in both FID and MSD detection methods (Fig. 3).
• Future work will focus on maximizing the sensitivity of the MS method by employing lower split 
values and selective ion monitoring.
• We are grateful to Loyola University Chicago for support of this research project through the 
Mulcahy Scholarship Program.
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